The number of privately treated tuberculosis cases in India: an estimation from drug sales data

The Lancet Infectious Diseases

Volumn 16, Issue 11, 2016, Pages 1255-1260

  Arinaminpathy, Nimalan ^a   Batra, Deepak ^b   Khaparde, Sunil ^c   Vualnam, Thongsuanmung ^b   Maheshwari, Nilesh ^b   Sharma, Lokesh ^b   Nair, Sreenivas A ^d   Dewan, Puneet ^e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMS   (India)

^c Central TB Division   (India)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; DRUG; TUBERCULOSTATIC AGENT;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; DISEASE SURVEILLANCE; DRUG MARKETING; HUMAN; INDIA; MAJOR CLINICAL STUDY; MONTE CARLO METHOD; ORGANIZATION AND MANAGEMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULOSIS; UNCERTAINTY; VALIDATION STUDY; ECONOMICS; PRIVATE SECTOR;

ANTITUBERCULAR AGENTS; HUMANS; INDIA; PHARMACEUTICAL PREPARATIONS; PRIVATE SECTOR; TUBERCULOSIS;

EID: 84994904748     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30259-6     Document Type: Article

References (18)

1. 1 WHO. Global tuberculosis report 2015, 2015, World Health Organization, Geneva http://www.who.int/tb/publications/global_report/en/ (accessed June 30, 2016).
2. 2 Satyanarayana, S, Nair, SA, Chadha, SS, et al. From where are tuberculosis patients accessing treatment in India? Results from a cross-sectional community based survey of 30 districts. PLoS One, 6, 2011, e24160.
3. 3 Sreeramareddy, CT, Qin, ZZ, Satyanarayana, S, Subbaraman, R, Pai, M, Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review. Int J Tuberc Lung Dis 18 (2014), 255–266.
4. 4 Udwadia, ZF, Pinto, LM, Uplekar, MW, Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades?. PLoS One, 5, 2010, e12023.
5. 5 Kapoor, SK, Raman, AV, Sachdeva, KS, Satyanarayana, S, How did the TB patients reach DOTS services in Delhi? A study of patient treatment seeking behavior. PLoS One, 7, 2012, e42458.
6. 6 Das, J, Kwan, A, Daniels, B, et al. Use of standardised patients to assess quality of tuberculosis care: a pilot, cross-sectional study. Lancet Infect Dis 15 (2015), 1305–1313.
7. 7 Herbert, N, George, A, Baroness Masham of Ilton, et al. World TB Day 2014: finding the missing 3 million. Lancet 383 (2014), 1016–1018.
8. 8 Pai, M, Dewan, P, Testing and treating the missing millions with tuberculosis. PLoS Med, 12, 2015, e1001805.
9. 9 Cowling, K, Dandona, R, Dandona, L, Improving the estimation of the tuberculosis burden in India. Bull World Health Org 92 (2014), 817–825.
10. 10 Wells, WA, Ge, CF, Patel, N, Oh, T, Gardiner, E, Kimerling, ME, Size and usage patterns of private TB drug markets in the high burden countries. PLoS One, 6, 2011, e18964.
11. 11 IMS Health. India pharmaceutical market reflection report. http://www.slideshare.net/IMSHealth_APAC/market-reflection-report-mar-2015, 2015 (accessed June 30, 2016).
12. 12 Sachdeva, KS, Kumar, A, Dewan, P, Kumar, A, Satyanarayana, S, New vision for Revised National Tuberculosis Control Programme (RNTCP): universal access—“reaching the un-reached”. Indian J Med Res 135 (2012), 690–694.
13. 13 Revised National Tuberculosis Control Programme. TB India 2015 annual status report. http://tbcindia.nic.in/showfile.php?lid=3166, 2015 (accessed June 30, 2016).
14. 14 Mehra, C, Ananthakrishnan, R, Why free medicines can transform TB management. http://www.thehindu.com/opinion/open-page/why-free-medicines-can-transform-tb-management/article7862511.ece, 2015 (accessed June 30, 2016).
15. 15 Murray, CJL, Ortblad, KF, Guinovart, C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384 (2014), 1005–1070.
16. 16 Kundu, D, Chopra, K, Khanna, A, Babbar, N, Padmini, TJ, Accelerating TB notification from the private health sector in Delhi, India. Indian J Tuberc 63 (2016), 8–12.
17. 17 Satyanarayana, S, Kwan, A, Daniels, B, et al. Use of standardised patients to assess antibiotic dispensing for tuberculosis by pharmacies in urban India: a cross-sectional study. Lancet Infect Dis, 2016 published online Aug 24, 2016. http://dx.doi.org/10.1016/S1473-3099(16)30215-8.
18. 18 Sachdeva, KS, Satyanarayana, S, Dewan, PK, et al. Source of previous treatment for re-treatment TB cases registered under the National TB control Programme, India, 2010. PLoS One, 6, 2011, e22061.